Fate Therapeutics’ (FATE) Hold Rating Reiterated at Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Fate Therapeutics (NASDAQ:FATE – Free Report) in a research note released on Thursday,Benzinga reports. FATE has been the subject of a number of other reports. Wall Street Zen upgraded shares of Fate Therapeutics from a “sell” rating to a “hold” rating in a research […]
Needham & Company LLC reiterated their hold rating on shares of Fate Therapeutics (NASDAQ:FATE – Free Report) in a research note released on Thursday,Benzinga reports. FATE has been the subject of a number of other reports. Wall Street Zen upgraded shares of Fate Therapeutics from a “sell” rating to a “hold” rating in a research […]
